BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7744702)

  • 1. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.
    Kobayashi H; Sakahara H; Endo K; Hosono M; Yao ZS; Toyama S; Konishi J
    Jpn J Cancer Res; 1995 Mar; 86(3):310-4. PubMed ID: 7744702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
    Zhang M; Sakahara H; Yao Z; Saga T; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
    Nucl Med Biol; 1997 Jan; 24(1):61-4. PubMed ID: 9080476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
    Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
    Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
    J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
    Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
    Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Jan; 20(1):147-54. PubMed ID: 19072537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
    Kassis AI; Jones PL; Matalka KZ; Adelstein SJ
    J Nucl Med; 1996 Feb; 37(2):343-52. PubMed ID: 8667075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody.
    Pimm MV; Fells HF; Perkins AC; Baldwin RW
    Nucl Med Commun; 1988 Nov; 9(11):931-41. PubMed ID: 3251178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidin chase can reduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
    Sato N; Saga T; Sakahara H; Nakamoto Y; Zhao S; Kuroki M; Iida Y; Endo K; Konishi J
    Jpn J Cancer Res; 2000 Jun; 91(6):622-8. PubMed ID: 10874215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.
    Nakamoto Y; Saga T; Sakahara H; Yao Z; Zhang M; Sato N; Zhao S; Nakada H; Yamashina I; Konishi J
    Nucl Med Biol; 1998 Feb; 25(2):95-9. PubMed ID: 9468022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidin chase reduces side effects of radioimmunotherapy in nude mice bearing human colon carcinoma.
    Li GP; Wang YX; Huang K; Zhang H; Zhang CF
    World J Gastroenterol; 2005 Apr; 11(13):1917-21. PubMed ID: 15800980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced blood accumulation of biotinylated monoclonal antibody A7 after the subsequent administration of avidin.
    Nishi H; Yamaguchi T; Otsuji E; Kotani T; Taniguchi K; Okamoto K; Yata Y; Tsuruta H; Takahashi T
    Cancer Lett; 1997 Dec; 120(2):127-34. PubMed ID: 9461028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased streptavidin uptake in tumors pretargeted with biotinylated antibody using a conjugate of streptavidin-fab fragment.
    Yao Z; Zhang M; Sakahara H; Saga T; Kobayashi H; Nakamoto Y; Toyama S; Konishi J
    Nucl Med Biol; 1998 Aug; 25(6):557-60. PubMed ID: 9751423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-seeking scintigraphy with radiolabeled biotinylated polyclonal IgG followed by the injection of avidin chase.
    Kobayashi H; Sakahara H; Endo K; Yao ZS; Konishi J
    Nucl Med Biol; 1996 Jan; 23(1):29-32. PubMed ID: 9004911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies.
    Paganelli G; Pervez S; Siccardi AG; Rowlinson G; Deleide G; Chiolerio F; Malcovati M; Scassellati GA; Epenetos AA
    Int J Cancer; 1990 Jun; 45(6):1184-9. PubMed ID: 2351490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
    J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin.
    Saga T; Weinstein JN; Jeong JM; Heya T; Lee JT; Le N; Paik CH; Sung C; Neumann RD
    Cancer Res; 1994 Apr; 54(8):2160-5. PubMed ID: 8174123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
    Otsuji E; Yamaguchi T; Yamamoto K; Matsumura H; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
    Jpn J Cancer Res; 1997 Feb; 88(2):205-12. PubMed ID: 9119750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.